|
N(3)-allyluridine
|
C049808 |
|
|
N(3)-allylthymidine
|
C049809 |
|
|
Patient Advocacy
|
D010344 |
[Promotion and protection of the rights of patients, frequently through a legal process.
] |
|
Patient Care Management
|
D010346 |
[Generating, planning, organizing, and administering medical and nursing care and services for patients.
] |
|
Patient Care Planning
|
D010347 |
[Usually a written medical and nursing care program designed for a particular patient.
] |
|
Patient Care Team
|
D010348 |
[Care of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient.
] |
|
Patient Compliance
|
D010349 |
[Voluntary cooperation of the patient in following a prescribed regimen.
] |
|
Pathology, Surgical
|
D010340 |
[A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.
] |
|
Pathology, Veterinary
|
D010341 |
[The field of veterinary medicine concerned with the causes of and changes produced in the body by disease.
] |
|
Patient Acceptance of Health Care
|
D010342 |
[Patients' willingness to receive health care.
] |
|
Patient Admission
|
D010343 |
[The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution.
] |
|
Glycogen Phosphorylase
|
D024981 |
[An enzyme that catalyzes the degradation of GLYCOGEN in animals by releasing glucose-1-phosphate from the terminal alpha-1,4-glycosidic bond. This enzyme exists in two forms: an active phosphorylated form ( PHOSPHORYLASE A) and an inactive un-phosphorylated form (PHOSPHORYLASE B). Both a and b forms of phosphorylase exist as homodimers. In mammals, the major isozymes of glycogen phosphorylase are found in muscle, liver and brain tissue.
] |
|
Glycogen Phosphorylase, Muscle Form
|
D024982 |
[An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in muscle. Mutation of the gene coding this enzyme is the cause of McArdle disease (GLYCOGEN STORAGE DISEASE TYPE V).
] |
|
Patient Identification Systems
|
D010355 |
[Organized procedures for establishing patient identity, including use of bracelets, etc.
] |
|
Patient Isolation
|
D010356 |
[The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection.
] |
|
Patient Isolators
|
D010357 |
[Equipment used to prevent contamination of and by patients, especially those with bacterial infections. This includes plastic surgical isolators and isolators used to protect immunocompromised patients.
] |
|
Patient Participation
|
D010358 |
[Patient involvement in the decision-making process in matters pertaining to health.
] |
|
Patient Readmission
|
D010359 |
[Subsequent admissions of a patient to a hospital or other health care institution for treatment.
] |
|
Patient Credit and Collection
|
D010350 |
[Accounting procedures for determining credit status and methods of obtaining payment.
] |
|
Patient Discharge
|
D010351 |
[The administrative process of discharging the patient, alive or dead, from hospitals or other health facilities.
] |
